Alejo Rodríguez‐Vida

机构：Hospital Del Mar, Parc de Salut, Municipal Institute for Medical Research, Hospital del Mar Research Institute, Centro de Investigación Biomédica en Red de Cáncer · ORCID：0000-0002-7304-6857

发表论文 224 篇 · 总被引 6344 次 · h-index 34

代表论文

• LBA2 Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible: The phase III KEYNOTE-905 study (2025 · Annals of Oncology · 被引 42)
• Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis (2025 · European Urology · 被引 34)
• SEOM–SOGUG clinical guideline for urothelial cancer (2025) (2025 · Clinical & Translational Oncology · 被引 7)
• Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes (2025 · Clinical Genitourinary Cancer · 被引 7)
• Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN Expression (2025 · International Journal of Molecular Sciences · 被引 4)
• Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer (2025 · Laboratory Investigation · 被引 3)